Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation: a Randomized Study

Trial Profile

Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation: a Randomized Study

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2015

At a glance

  • Drugs Everolimus (Primary) ; Antithymocyte globulin; Methylprednisolone; Mycophenolate sodium; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics
  • Acronyms EVERTWIST
  • Most Recent Events

    • 24 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 08 Sep 2013 Interim results (n=33) presented at the 16th Congress of the European Society for Organ Transplantation.
    • 23 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top